It has been reported in the literature that Ankrd1 can be regulated by Ang II through its type 1 receptor AT1R and directly participate in the process of cardiomyocyte apoptosis and hypertrophy and has become a new potential target for treatment of heart failure [48]. This evidence concerns the gene AGTR1 and heart failure.